Zantac Settlement Payout: What Can Claimants Expect? (2025)
Contributor
Reviewed By Adam Ramirez, J.D.
Editor
Summary
- GSK agreed to pay $2.2 billion to settle U.S. state court cases.
- Zantac manufacturers Sanofi and Pfizer also settled cases
- The average Zantac settlement payout is $25,000; some may get more
Zantac lawsuits arose from its active ingredient, ranitidine, which degrades into a carcinogenic substance. Ranitidine can cause cancer as it travels through the digestive tract. The danger was substantial enough that the FDA issued a recall.
But how much can you get from a Zantac settlement payout? Here are the findings so far as these lawsuits proceed.
Free Zantac Lawsuit Case Review
Preparing Case Review Form. ConsumerShield is transforming the way consumers experience law.
Recent Zantac Settlement News
On October 9, 2024, GSK agreed to pay $2.2 billion to settle most U.S. state court lawsuits. The settlement covers 80,000 cases–about 93% of pending cases. GSK also agreed to settle a whistleblower case filed by a laboratory in Connecticut.
Another defendant, Boehringer Ingelheim, continues denying wrongdoing and is not settling claims.
In September 2024, two Zantac cases settled in California. One claimed Zantac caused bladder cancer, and the other involved colorectal illness. Both settlements are confidential.
Sanofi settled cases earlier this year in April. That settlement resolved 4,000 cases for $100 million, and claimants received an average payment of $25,000. Another settlement with Pfizer settled 10,000 cases for $250 million, which also averaged approximately $25,000 per claim.
It appears defendants settle the solid cases and take the weak ones to court. So far, plaintiffs have not received favorable verdicts from juries. The record shows no wins, two mistrials, and two verdicts for defendants. While this seems discouraging, litigation continues, and results may change soon.
Average Zantac Settlement Payout
Law firms estimate that a Zantac settlement payout could be as high as $500,000, with an overall average of $25,000. However, this does not guarantee payments of those amounts. Payments depend on settlement amounts and damages suffered by plaintiffs.
Dangerous drug cases, especially those in multi-district litigation or class actions, frequently divide plaintiffs into tiers. Roundup lawsuits, for example, use this system to manage the sheer number of cases and develop a way to assess the seriousness of each claim.
The MDL or other Zantac class actions are not guaranteed to use a tier system. But if the courts decide to implement one, the anticipated settlement tiers may be:
- Tier I injuries: Stomach, breast, pancreatic or prostate cancer with payouts from $300,000 to $500,000
- Tier II injuries: Liver, bladder or kidney cancer with payouts from $100,000 to $500,000
- Tier III injuries: Other non-cancer injuries like blood and digestive disorders with payouts from $30,000 to $75,000
Juries assess individual cases (filed independently) on a plaintiff’s damages and unique facts. For example, when determining damages, a jury may consider:
- Type of cancer
- Medical expenses
- Impact on quality of life
- Lost wages and diminished earning capacity
- Loss of support and companionship (wrongful death cases)
- Los income (wrongful death cases)
Free Zantac Lawsuit Case Review
Preparing Case Review Form. ConsumerShield is transforming the way consumers experience law.
How to Qualify for Zantac Lawsuit Settlements
Attorneys are still accepting cases for Zantac lawsuits. However, your situation must fit specific facts, including:
- Took Zantac regularly for one year between 1983 and 2019
- Diagnosed with cancer
- Cancer arose within a year after ending Zantac use
Courts used to limit claims to digestive system cancers. However, on November 15, 2024, a California court transferred a breast cancer claim to the MDL in the Southern District of Florida. So, do not hesitate to contact an attorney if your cancer is different from the ones listed in an MDL.
Contact ConsumerShield for More Information
If you developed cancer after using Zantac, you may have a claim for damages. An attorney can help you. ComsumerShield educates consumers and refers to attorneys who can assess your case and file a claim. Contact us for a free case evaluation.
Free Zantac Lawsuit Case Review
Preparing Case Review Form. ConsumerShield is transforming the way consumers experience law.
Zantac Lawsuit Knowledge Base
Read the latest information on Zantac Lawsuit and find answers to your questions. Currently there are 3 topics about Zantac Lawsuit Lawsuits.
Settlements & Payouts
Frequently Asked Questions
-
One set of Zantac lawsuits gathered in an MDL in Florida was dismissed after a judge ruled the expert witnesses could not testify. A different set of MDL cases continues in Delaware after overcoming the hurdle that ended the Florida lawsuits. Drug companies won the first trial in Delaware.
-
Although drug companies scored a win in Delaware and dismissals in Florida, they are settling cases. GSK settled an individual lawsuit on undisclosed terms. Sanofi and Pfizer settled 14,000 lawsuits for a combined $350 million or an average of $25,000 each, although settlement tiers have not been disclosed.
-
There is no way to predict how long the Zantac lawsuits will take. However, the first cases have gone to trial. The drug companies have won one case and settled another. Unless the drug companies offer a global settlement, more cases will soon follow.
-
Multidistrict litigations are often effective at pressuring manufacturers to settle. Each case retains its individual character, and the drug companies face several years of trial after trial. Once juries start returning verdicts in these cases, plaintiffs and drug companies will have a better picture of possible settlement timelines and terms.
